I. Paul Singh, MD; and Steve Charles, MD, FACS, FICS
Show Description +
In this special episode of Innovation Journal Club, I. Paul Singh, MD, sits down with Steve Charles, MD, to hear his perspective on two innovations in retina. In the first segment, Dr. Charles discusses the recent regulatory approval of Susvimo (Genentech) for the treatment of wet AMD. Following, Dr. Charles provides an overview of autologous retina transfer and how retina surgeons use this technique to repair complex macular holes—stay tuned to the end for a series of case presentations.
Posted: 8/15/2022
I. Paul Singh, MD; and Steve Charles, MD, FACS, FICS
In this special episode of Innovation Journal Club, I. Paul Singh, MD, sits down with Steve Charles, MD, to hear his perspective on two innovations in retina. In the first segment, Dr. Charles discusses the recent regulatory approval of Susvimo (Genentech) for the treatment of wet AMD. Following, Dr. Charles provides an overview of autologous retina transfer and how retina surgeons use this technique to repair complex macular holes—stay tuned to the end for a series of case presentations.
Posted: 8/15/2022
Supported by
Please log in to leave a comment.